Janssen Geel, the chemical production site of the international pharmaceutical company Johnson & Johnson (J&J), received the Factory of the Future Award in 2019 as the first company in the chemical and pharmaceutical industries. Of all medicines by the American parent company J&J, two out of three synthetic active ingredients are made in Geel. The production site thus plays a strategic role in the worldwide launch of new medicines.
The Factory of the Future Award is an initiative by technology federation Agoria and the technological innovation centre Sirris, in collaboration with essenscia vlaanderen, the sector federation of chemical and life sciences industry, and Catalisti, the innovation cluster for the chemical and plastics industry in Flanders. Centexbel, Fedustria Vlaanderen, Fevia Vlaanderen and Flanders’ FOOD are also partners.
Janssen Geel is one of the most progressive and successful production centres of active chemicals for medicines in the world and an indispensable link in the worldwide production network of J&J, one of the largest pharmaceutical companies in the world with more than 40,000 employees, 5,200 of whom work in Belgium.
Meanwhile, Janssen Geel continues to build the factory of the future. In recent years, the largest investment ever made by J&J in Belgium, totalling 130 million euros, took place in Geel with the construction of the new Chemical Development Pilot Plant (CDPP). This reinforces the strategic position of the production site in the production of active ingredients for the launch of new medicines.